4 results match your criteria: "Hines VA Hospital and Loyola University Medical Center[Affiliation]"
Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?
Am J Gastroenterol
March 2022
RM Alden Research Laboratory and the David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use.
Antibiotics (Basel)
April 2021
RM Alden Research Laboratory and the David Geffen School of Medicine at UCLA, Los Angeles, CA 90230, USA.
Medical care for patients hospitalized with COVID-19 is an evolving process. Most COVID-19 inpatients (58-95%) received empiric antibiotics to prevent the increased mortality due to ventilator-associated pneumonia and other secondary infections observed in COVID-19 patients. The expected consequences of increased antibiotic use include antibiotic-associated diarrhea (AAD) and infections (CDI).
View Article and Find Full Text PDFPathway to Prevention of Nosocomial Clostridium difficile Infection.
Clin Infect Dis
May 2015
Mount Sinai Hospital, University of Toronto, Ontario, Canada.
Background: To address the significant morbidity and mortality rates associated with nosocomial Clostridium difficile-associated diarrhea (CDAD), a series of recommendations and a pathway to prevention were developed.
Methods: An expert panel of infectious disease (ID) specialists participated in a modified Delphi process with specific objectives: (1) conduct a review for CDAD and prevention; (2) develop statements based upon panel members' opinions; (3) hold a panel meeting during the 2012 IDWeek; and (4) review the final recommendations and prevention pathway prior to submission for publication.
Results: The panel voted on (1) antibiotic stewardship (7 of 8 panelists); (2) reduction of other potentially modifiable risk factors (variable); (3) utilization of specific probiotics to prevent C.
Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Int J Infect Dis
November 2012
Hines VA Hospital and Loyola University Medical Center, Hines, Chicago, IL 60141, USA.
Background: The efficacy of probiotics for the prevention of Clostridium difficile infection (CDI) is highly controversial, particularly with regard to the prevention of recurrent CDI. We hypothesize that primary prevention of CDI among patients receiving antibiotics might be a more achievable goal for probiotics than prevention in patients with previous CDI where the host flora is markedly altered.
Methods: We conducted a literature search for randomized, placebo-controlled efficacy studies of probiotic use among adults receiving antibiotics, in which CDI was one of the outcomes measured.